Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Headache | 2 | 2024 | 151 | 1.600 |
Why?
|
| Terminology as Topic | 1 | 2024 | 204 | 0.830 |
Why?
|
| Transgender Persons | 2 | 2023 | 172 | 0.800 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 2 | 0.740 |
Why?
|
| Headache Disorders, Primary | 1 | 2021 | 4 | 0.740 |
Why?
|
| Headache Disorders, Secondary | 1 | 2021 | 4 | 0.740 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 245 | 0.740 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 196 | 0.710 |
Why?
|
| Biomedical Research | 2 | 2024 | 640 | 0.710 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 93 | 0.680 |
Why?
|
| White Matter | 2 | 2020 | 135 | 0.680 |
Why?
|
| Drug Interactions | 1 | 2021 | 397 | 0.650 |
Why?
|
| Machine Learning | 1 | 2024 | 441 | 0.650 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 52 | 0.640 |
Why?
|
| Brain Diseases | 1 | 2020 | 134 | 0.620 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 190 | 0.590 |
Why?
|
| Hearing Loss | 1 | 2020 | 209 | 0.530 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1514 | 0.520 |
Why?
|
| Neurology | 3 | 2023 | 103 | 0.500 |
Why?
|
| Headache Disorders | 2 | 2024 | 17 | 0.400 |
Why?
|
| Brain | 2 | 2023 | 2677 | 0.390 |
Why?
|
| Testosterone | 2 | 2023 | 372 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3397 | 0.200 |
Why?
|
| Sertraline | 2 | 2013 | 30 | 0.200 |
Why?
|
| Brain Mapping | 2 | 2023 | 575 | 0.170 |
Why?
|
| Estrogens | 1 | 2023 | 348 | 0.170 |
Why?
|
| Migraine Disorders | 1 | 2021 | 101 | 0.170 |
Why?
|
| Neuroimaging | 2 | 2020 | 279 | 0.160 |
Why?
|
| Hearing Tests | 1 | 2020 | 47 | 0.160 |
Why?
|
| Sex Distribution | 1 | 2020 | 359 | 0.160 |
Why?
|
| Depressive Disorder, Major | 2 | 2013 | 345 | 0.160 |
Why?
|
| Transition to Adult Care | 1 | 2020 | 82 | 0.150 |
Why?
|
| Research Personnel | 1 | 2020 | 156 | 0.150 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 111 | 0.150 |
Why?
|
| Neonatal Screening | 1 | 2020 | 163 | 0.150 |
Why?
|
| Career Choice | 1 | 2020 | 206 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 439 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3384 | 0.140 |
Why?
|
| Humans | 13 | 2024 | 129847 | 0.130 |
Why?
|
| Prevalence | 1 | 2023 | 2564 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2012 | 735 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2724 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3089 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2023 | 14553 | 0.110 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 229 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2021 | 1035 | 0.100 |
Why?
|
| Gyrus Cinguli | 1 | 2013 | 79 | 0.100 |
Why?
|
| Puberty | 2 | 2012 | 143 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2023 | 7158 | 0.100 |
Why?
|
| Gray Matter | 1 | 2013 | 81 | 0.100 |
Why?
|
| Pediatrics | 1 | 2020 | 1074 | 0.100 |
Why?
|
| Personality Inventory | 1 | 2012 | 139 | 0.100 |
Why?
|
| Sexual Maturation | 1 | 2012 | 52 | 0.090 |
Why?
|
| Temporal Lobe | 1 | 2012 | 86 | 0.090 |
Why?
|
| Male | 8 | 2023 | 63759 | 0.090 |
Why?
|
| Female | 7 | 2023 | 68829 | 0.080 |
Why?
|
| Adolescent | 4 | 2023 | 20451 | 0.080 |
Why?
|
| Child | 4 | 2023 | 20962 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2020 | 5772 | 0.080 |
Why?
|
| Infant | 1 | 2020 | 9018 | 0.060 |
Why?
|
| Adult | 2 | 2023 | 35634 | 0.050 |
Why?
|
| Social Stigma | 1 | 2021 | 117 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 252 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 1016 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 622 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 759 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2020 | 411 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 9 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 125 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 20 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 456 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 494 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 154 | 0.020 |
Why?
|
| Amygdala | 1 | 2012 | 192 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 411 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2012 | 301 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 701 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 10241 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2012 | 505 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 844 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1973 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 3161 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 12467 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 22107 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 31177 | 0.010 |
Why?
|